Data as of Dec 19
| -0.05 / -1.24%|
The 7 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 4.18. The median estimate represents a +100.50% increase from the last price of 3.99.
The current consensus among 9 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.